Background Image
Previous Page  160 / 182 Next Page
Information
Show Menu
Previous Page 160 / 182 Next Page
Page Background

159

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

85

Erdine S. Interventional treatment of cancer pain. European Journal of Cancer Supple-

ments 2005; 3: 97-106.

86

European Medicines Agency. Abstral  100, 200, 300, 400, 600, 800 microgram sublin-

gual tablets: summary of product characteristics [online]. Verfügbar online über URL:

http://emc.medicines.org.uk/document.aspx?documentId=21371

[aufgerufen am

31.10.2012].

87

European Medicines Agency. Actiq 200, 400, 600, 800, 1200, 1600 microgram com-

pressed lozenge: summary of product characteristics [online]. Verfügbar online über

URL:

http://www.medicines.org.uk/emc/medicine/11145/SPC/Actiq

[aufgerufen am

31.10.2012].

88

European Medicines Agency. Effentora buccal tablets: summary of product characte-

ristics [online]. Verfügbar online über URL:

http://www.emea.europa.eu/human

docs/

Humans/EPAR/effentora/effentora.htm [aufgerufen am 31.10.2012].

89

European Medicines Agency. European public assessment report (EPAR): Instanyl

(fentanyl) [online]. Verfügbar online über URL:

http://www.ema.europa.eu/ema/

index.jsp?curl=pages/medicines/human/medicines/000959/human_med_000838.

jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124 [aufgerufen

am 31.10.2012].

90

European Medicines Agency. European public assessment report (EPAR): Effentora

(fentanyl) [online].Verfügbar online über URL:

http://www.ema.europa.eu/ema/

index.jsp?curl=pages/medicines/human/medicines/000833/human_med_000754.

jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124 [aufgerufen

am 31.10.2012].

91

European Medicines Agency. Instanyl nasal spray, solution: summary of product cha-

racteristics [online]. Verfügbar online über URL:

http://www.emea.europa

. eu/human-

docs/PDFs/EPAR/instanyl/emea-combined-h959en.pdf [aufgerufen am 31.10.2012].

92

Fallon M, Reale C, Davies A, Lux AE, Kumar K, Stachowiak A, Galvez R; Fentanyl Nasal

Spray Study 044 Investigators Group. Efficacy and safety of fentanyl pectin nasal

spray compared with immediate-release morphine sulfate tablets in the treatment of

breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-

dummy multiple-crossover study. J Support Oncol. 2011; 9(6): 224-231.

93

Fallon MT, Gatti A, Gatti A et al. Fentanyl pectin nasal spray provides clinically meaning-

ful pain relief and a more rapid onset of analgesia compared with immediate-release

morphine sulfate in breakthrough cancer pain. Palliative Med 2010; 24 (S24).

94

Farquhar-Smith P. Anaesthetic / interventional techniques. In: Davies AN (Hrsg.),

Cancer-related bone pain. Oxford: Oxford University Press; 2007, 85-97.

95

Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate:

randomized, double-blinded, placebo controlled trial for treatment of breakthrough

pain in cancer patients. J Natl Cancer Inst 1998; 90 (8): 611-616.

96

FENTORA (fentanyl buccal tablet): US prescribing information. Frazer (PA): Cephalon

Inc. [online]. Verfügbar online über URL:

http://dailymed.nlm.nih.gov/dailymed/drugIn-

fo.cfm?id=59775 [aufgerufen am 31.10.2012].

Literaturverzeichnis